Mira Jung
Gründer bei SHUTTLE PHARMACEUTICALS HOLDINGS, INC.
Vermögen: 427 484 $ am 30.04.2024
Profil
Mira Jung is the founder of Shuttle Pharmaceuticals, Inc. (founded in 2012) and Shuttle Pharmaceuticals Holdings, Inc. (founded in 2012) where she holds the title of Scientific Director and Chief Scientific Officer-Biology respectively.
Dr. Jung also worked as a Professor at Georgetown University School of Medicine.
She obtained her graduate and doctorate degrees from the University of Kansas.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
21.03.2024 | 1 071 388 ( 6,38% ) | 427 484 $ | 30.04.2024 |
Aktive Positionen von Mira Jung
Unternehmen | Position | Beginn |
---|---|---|
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. | Gründer | 18.12.2012 |
Shuttle Pharmaceuticals, Inc.
Shuttle Pharmaceuticals, Inc. BiotechnologyHealth Technology Shuttle Pharmaceuticals, Inc. operates as a pharmaceutical company which engages in the development and commercialization of drugs. It focuses on innovative drugs for sensitizing cancers to and protecting normal tissue from the effects of radiation therapy. The firm's products include novel HDAC inhibitor cancer drug candidates. The company was founded by Anatoly Dritschilo, Milton Brown, and Mira Jung in December 2012 and is headquartered in Rockville, MD. | Gründer | 01.12.2012 |
Ehemalige bekannte Positionen von Mira Jung
Unternehmen | Position | Ende |
---|---|---|
Georgetown University School of Medicine | Corporate Officer/Principal | - |
Ausbildung von Mira Jung
University of Kansas | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Shuttle Pharmaceuticals, Inc.
Shuttle Pharmaceuticals, Inc. BiotechnologyHealth Technology Shuttle Pharmaceuticals, Inc. operates as a pharmaceutical company which engages in the development and commercialization of drugs. It focuses on innovative drugs for sensitizing cancers to and protecting normal tissue from the effects of radiation therapy. The firm's products include novel HDAC inhibitor cancer drug candidates. The company was founded by Anatoly Dritschilo, Milton Brown, and Mira Jung in December 2012 and is headquartered in Rockville, MD. | Health Technology |